Natera Price to Sales Ratio 2014-2025 | NTRA
Historical PS ratio values for Natera (NTRA) over the last 10 years. The current P/S ratio for Natera as of July 08, 2025 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Natera P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2025-07-08 | 158.48 | 10.96 | |
| 2025-03-31 | 141.41 | $14.46 | 9.78 |
| 2024-12-31 | 158.30 | $13.78 | 11.49 |
| 2024-09-30 | 126.95 | $12.67 | 10.02 |
| 2024-06-30 | 108.29 | $11.44 | 9.46 |
| 2024-03-31 | 91.46 | $10.38 | 8.81 |
| 2023-12-31 | 62.64 | $9.50 | 6.60 |
| 2023-09-30 | 44.25 | $9.00 | 4.92 |
| 2023-06-30 | 48.66 | $8.84 | 5.50 |
| 2023-03-31 | 55.52 | $8.59 | 6.46 |
| 2022-12-31 | 40.17 | $8.46 | 4.75 |
| 2022-09-30 | 43.82 | $8.16 | 5.37 |
| 2022-06-30 | 35.44 | $7.70 | 4.60 |
| 2022-03-31 | 40.68 | $7.26 | 5.60 |
| 2021-12-31 | 93.39 | $6.99 | 13.36 |
| 2021-09-30 | 111.44 | $6.47 | 17.24 |
| 2021-06-30 | 113.53 | $5.97 | 19.02 |
| 2021-03-31 | 101.54 | $5.45 | 18.63 |
| 2020-12-31 | 99.52 | $4.89 | 20.33 |
| 2020-09-30 | 72.24 | $4.70 | 15.36 |
| 2020-06-30 | 49.86 | $4.60 | 10.85 |
| 2020-03-31 | 29.86 | $4.59 | 6.50 |
| 2019-12-31 | 33.69 | $4.46 | 7.56 |
| 2019-09-30 | 32.80 | $4.42 | 7.43 |
| 2019-06-30 | 27.58 | $4.39 | 6.28 |
| 2019-03-31 | 20.62 | $4.46 | 4.63 |
| 2018-12-31 | 13.96 | $4.54 | 3.07 |
| 2018-09-30 | 23.94 | $4.36 | 5.50 |
| 2018-06-30 | 18.82 | $4.32 | 4.35 |
| 2018-03-31 | 9.27 | $4.15 | 2.23 |
| 2017-12-31 | 8.99 | $3.93 | 2.29 |
| 2017-09-30 | 12.89 | $3.83 | 3.37 |
| 2017-06-30 | 10.86 | $3.82 | 2.84 |
| 2017-03-31 | 8.87 | $3.84 | 2.31 |
| 2016-12-31 | 11.71 | $4.14 | 2.83 |
| 2016-09-30 | 11.11 | $5.29 | 2.10 |
| 2016-06-30 | 12.07 | $5.26 | 2.30 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $21.640B | $1.697B |
| Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $143.621B | 26.94 |
| CVS Health (CVS) | United States | $84.680B | 10.52 |
| Elevance Health (ELV) | United States | $78.955B | 10.19 |
| Cencora (COR) | United States | $57.765B | 20.10 |
| DiDi Global (DIDIY) | China | $23.297B | 24.75 |
| Labcorp Holdings (LH) | United States | $21.549B | 17.48 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.690B | 0.00 |
| Solventum (SOLV) | United States | $12.990B | 13.75 |
| CochLear (CHEOY) | Australia | $12.847B | 0.00 |
| ICON (ICLR) | Ireland | $12.241B | 11.38 |
| Revvity (RVTY) | United States | $11.865B | 20.42 |
| Viatris (VTRS) | United States | $10.868B | 3.73 |
| Avantor (AVTR) | United States | $9.370B | 13.61 |
| Medpace Holdings (MEDP) | United States | $9.269B | 24.62 |
| HealthEquity (HQY) | United States | $8.917B | 39.06 |
| Sonic Healthcare (SKHHY) | Australia | $8.417B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.779B | 15.24 |
| Caris Life Sciences,�Inc (CAI) | United States | $6.688B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.952B | 29.17 |
| BrightSpring Health Services (BTSG) | United States | $3.769B | 34.58 |
| Sotera Health (SHC) | United States | $3.290B | 18.69 |
| Surgery Partners (SGRY) | United States | $2.853B | 37.10 |
| Alignment Healthcare (ALHC) | United States | $2.712B | 0.00 |
| Concentras Parent (CON) | United States | $2.615B | 15.11 |
| Organon (OGN) | United States | $2.587B | 2.75 |
| GeneDx Holdings (WGS) | United States | $2.432B | 93.65 |
| Progyny (PGNY) | United States | $2.080B | 45.79 |
| PACS (PACS) | United States | $1.972B | 0.00 |
| Ardent Health (ARDT) | United States | $1.970B | 8.40 |
| Premier (PINC) | United States | $1.805B | 13.70 |
| GoodRx Holdings (GDRX) | United States | $1.729B | 34.57 |
| Teladoc Health (TDOC) | United States | $1.493B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.271B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.159B | 8.82 |
| CareDx (CDNA) | United States | $1.072B | 16.74 |
| Agilon Health (AGL) | United States | $0.989B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.846B | 7.92 |
| Nutex Health (NUTX) | United States | $0.766B | 11.59 |
| QDM (QDMI) | Hong Kong, SAR China | $0.729B | 0.00 |
| Embecta (EMBC) | United States | $0.610B | 4.11 |
| InnovAge Holding (INNV) | United States | $0.574B | 0.00 |
| LifeMD (LFMD) | United States | $0.544B | 0.00 |
| SBC Medicals (SBC) | United States | $0.504B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.468B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.465B | 10.47 |
| Omada Health (OMDA) | $0.450B | 0.00 | |
| So-Young (SY) | China | $0.423B | 0.00 |
| Enhabit (EHAB) | United States | $0.370B | 30.42 |
| Performant Healthcare (PHLT) | United States | $0.333B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.324B | 0.00 |
| Beauty Health (SKIN) | United States | $0.265B | 0.00 |
| Oncology Institute (TOI) | United States | $0.223B | 0.00 |
| DocGo (DCGO) | United States | $0.158B | 25.83 |
| Pheton Holdings (PTHL) | China | $0.128B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.102B | 0.00 |
| KindlyMD (NAKA) | United States | $0.078B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.067B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.062B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| ModivCare (MODV) | United States | $0.055B | 0.00 |
| Biodesix (BDSX) | United States | $0.043B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.037B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.034B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.026B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.012B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |